Price Alert

Charles River Laboratorie... (CRL)

NYSE: CRL · Real-Time Price · USD

155.70

0.70 (0.45%)

At close: Aug 14, 2025, 3:59 PM

156.34

0.41%

Pre-market: Aug 15, 2025, 08:32 AM EDT

Charles River Laboratories International Statistics

Share Statistics

Charles River Laboratories International has 49.12M shares outstanding. The number of shares has increased by -4.87% in one year.

Shares Outstanding	49.12M
Shares Change (YoY)	-4.87%
Shares Change (QoQ)	-3.96%
Owned by Institutions (%)	99.99%
Shares Floating	48.64M
Failed to Deliver (FTD) Shares	25
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 2.32M, so 4.53% of the outstanding shares have been sold short.

Short Interest	2.32M
Short % of Shares Out	4.53%
Short % of Float	5.87%
Short Ratio (days to cover)	3.5

Valuation Ratios

The PE ratio is 928.9 and the forward PE ratio is 14.12. Charles River Laboratories International's PEG ratio is -9.49.

PE Ratio	928.9
Forward PE	14.12
PS Ratio	2.36
Forward PS	1.8
PB Ratio	2.76
P/FCF Ratio	19.07
PEG Ratio	-9.49

Financial Ratio History

Enterprise Valuation

Charles River Laboratories International has an Enterprise Value (EV) of 12.09B.

EV / Sales	2.99
EV / EBITDA	20.81
EV / EBIT	16.46
EV / FCF	24.11

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.79.

Current Ratio	1.41
Quick Ratio	1.13
Debt / Equity	0.79
Debt / EBITDA	4.69
Debt / FCF	5.43
Interest Coverage	1.8

Financial Efficiency

Return on Equity is 0.3% and Return on Invested Capital is 0.95%.

Return on Equity	0.3%
Return on Assets	0.14%
Return on Invested Capital	0.95%
Revenue Per Employee	$216.58K
Profits Per Employee	$550.64
Employee Count	18,700
Asset Turnover	0.54
Inventory Turnover	9.76

Taxes

Income Tax	67.82M
Effective Tax Rate	72.84%

Stock Price Statistics

The stock price has increased by -23.42% in the last 52 weeks. The beta is 1.48, so Charles River Laboratories International's price volatility has been higher than the market average.

Beta	1.48
52-Week Price Change	-23.42%
50-Day Moving Average	154.93
200-Day Moving Average	162.47
Relative Strength Index (RSI)	37.47
Average Volume (20 Days)	989,171

Income Statement

In the last 12 months, Charles River Laboratories International had revenue of 4.05B and earned 10.3M in profits. Earnings per share was 0.2.

Revenue	4.05B
Gross Profit	1.33B
Operating Income	227.35M
Net Income	10.3M
EBITDA	581.14M
EBIT	219.4M
Earnings Per Share (EPS)	0.2

Full Income Statement

Balance Sheet

The company has 194.61M in cash and 2.72B in debt, giving a net cash position of -2.53B.

Cash & Cash Equivalents	194.61M
Total Debt	2.72B
Net Cash	-2.53B
Retained Earnings	1.81B
Total Assets	7.56B
Working Capital	389.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 734.58M and capital expenditures -232.97M, giving a free cash flow of 501.61M.

Operating Cash Flow	734.58M
Capital Expenditures	-232.97M
Free Cash Flow	501.61M
FCF Per Share	9.76

Full Cash Flow Statement

Margins

Gross margin is 32.88%, with operating and profit margins of 5.61% and 0.25%.

Gross Margin	32.88%
Operating Margin	5.61%
Pretax Margin	2.3%
Profit Margin	0.25%
EBITDA Margin	14.35%
EBIT Margin	5.61%
FCF Margin	12.39%

Dividends & Yields

CRL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.11%
FCF Yield	5.24%

Dividend Details

Analyst Forecast

The average price target for CRL is $183, which is 23% higher than the current price. The consensus rating is "Hold".

Price Target	$183
Price Target Difference	23%
Analyst Consensus	Hold
Analyst Count	13

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$1
Lynch Upside	-99.33%
Graham Number	17.43
Graham Upside	-88.29%

Scores

Altman Z-Score	2.05
Piotroski F-Score	4